Shinkin Capital
51
2M
46
0.10
4
- Areas of investment
Summary
The fund was located in Asia if to be more exact in Japan. The main office of represented VC is situated in the Tokyo.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Linkwiz, REGiMMUNE Corporation. Among the most popular fund investment industries, there are Biopharma, Robotics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Shinkin Capital, startups are often financed by Japan Asia Investment, Yasuda Enterprise Development, SMBC Venture Capital. The meaningful sponsors for the fund in investment in the same round are SMBC Venture Capital, Hamashin Lease, Shizuoka Capital Wealth Management. In the next rounds fund is usually obtained by Venture Labo Investment Co.,Ltd, SMBC Venture Capital, Toppan Forms.
The top activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 1 - 5 millions dollars.
Investments analytics
Analytics
- Total investments
- 51
- Lead investments
- 0
- Exits
- 4
- Follow on index
- 0.10
- Investments by industry
- Manufacturing (13)
- Food and Beverage (9)
- Biotechnology (7)
- Construction (6)
- Agriculture (5) Show 67 more
- Investments by region
-
- Japan (50)
- China (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 24
- Group Appearance index
- 0.43
- Avg. company exit year
- 3
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| NIHON AGRI | 30 May 2024 | Agriculture, Farming | Late Stage Venture | 38M | Minato, Japan |
| REGiMMUNE Corporation | 01 Feb 2012 | Biotechnology, Health Diagnostics, Biopharma | Late Stage Venture | 5M | Japan, Chiyoda |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.